Research Communications of the 36th ECVIM-CA Congress 10–12 September 2026 Estrel Berlin Berlin, Germany

not responsible for the content or dosage recommendations in the abstracts.The abstracts are not peer reviewed before publication.The opinions expressed in the abstracts are those of the author(s) and may not represent the views or position of the ECVIM-CA.The authors are solely responsible for the content of the abstracts.Oral Schedule ESVC -European Society of Veterinary Cardiology Thursday 10 September ESVC-O-1 11.20 Johnson Evaluation of artificial intelligence-assisted cardiac auscultation technology for murmur and arrhythmia detection in dogs and cats ESVC-O-2 11.35 Serres Use of Bimod Vet® device for the quantitative assessment of heart murmur severity in dogs with precongestive mitral valve disease: repeatability, correlation with echocardiographic markers of disease severity and accuracy for the distinction of B1/B2 stage ESVC-O-3 11.50 Monge-Utrilla Left heart chambers volume-to-body weight ratio in dogs with myxomatous mitral valve disease as a predictive factor for congestive heart failure ESVC-O-4 12.05 Seu Volumetric assessment of left heart remodeling and its prognostic value in dogs with myxomatous mitral valve disease ESVC-O-5 12.20 Monge-Utrilla Pulmonary vein-to-body weight ratio in dogs with myxomatous mitral valve disease as a predictive factor for congestive heart failure ESVC-O-6 12.35 Stauthammer Volatile organic compound breath analysis in dogs with degenerative valve disease ESVC-O-7 12.50 Carlson Sacubitril/valsartan therapy permits diuretic liberation in eleven dogs with stage C myxomatous mitral valve disease ESVC-O-8 14.25 Boscia Retrospective review on the use of injectable furosemide in acute congestive heart failure in 165 dogs and 105 cats (2020-2025) ESVC-O-9 14.40 Sajadihezaveh Urinary sodium concentration is associated with time to decongestion in dogs and cats with congestive heart failure ESVC-O-10 14.55 Isayama Determinants of hemodilution and transfusion during cardiopulmonary bypass in small-breed dogs undergoing mitral valve repair ESVC-O-11 15.10 Takeuchi Outcomes of mitral valve repair surgery in dogs weighing ≤2.0 kilograms: a retrospective cohort study ESVC-O-13 15.25 Skotarek Comparison of two speckle-tracking echocardiography methods for left ventricular strain assessment in healthy dogs and dogs with systemic disease ESVC-O-14 15.40 Skotarek Cardiac troponin I and N-terminal pro-B-type natriuretic peptide in septic dogs: association with echocardiographic indices of systolic function and diagnostic utility ESVC-O-15 15.55 Assuncao Cardiac reverse remodelling in dogs with angiostrongylus vasorum-associated pulmonary hypertension